MJN110 is primarily researched for its potential therapeutic applications in the field of neuroscience and pain management. It is being studied for its ability to modulate the endocannabinoid system, which plays a crucial role in regulating pain, inflammation, and neurological functions. Preliminary studies suggest it may have analgesic properties, making it a candidate for treating chronic pain conditions. Additionally, its interaction with cannabinoid receptors is being explored for potential benefits in neurodegenerative diseases, such as Parkinson's and Alzheimer's. Researchers are also investigating its anti-inflammatory effects, which could be useful in managing conditions like multiple sclerosis or arthritis. However, further studies are needed to fully understand its efficacy, safety, and potential applications in clinical settings.